Search Results - "Sicotte, N.L."

Intensity warping for multisite MRI harmonization by Wrobel, J., Martin, M.L., Bakshi, R., Calabresi, P.A., Elliot, M., Roalf, D., Gur, R.C., Gur, R.E., Henry, R.G., Nair, G., Oh, J., Papinutto, N., Pelletier, D., Reich, D.S., Rooney, W.D., Satterthwaite, T.D., Stern, W., Prabhakaran, K., Sicotte, N.L., Shinohara, R.T., Goldsmith, J.

“…In multisite neuroimaging studies there is often unwanted technical variation across scanners and sites. These “scanner effects” can hinder detection of…”
Get full text

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial by Ontaneda, D., Sati, P., Raza, P., Kilbane, M., Gombos, E., Alvarez, E., Azevedo, C., Calabresi, P., Cohen, J.A., Freeman, L., Henry, R.G., Longbrake, E.E., Mitra, N., Illenberger, N., Schindler, M., Moreno-Dominguez, D., Ramos, M., Mowry, E., Oh, J., Rodrigues, P., Chahin, S., Kaisey, M., Waubant, E., Cutter, G., Shinohara, R., Reich, D.S., Solomon, A., Sicotte, N.L.

“…•Approximately one in five patients with MS do not have the disease.•The central vein differentiates multiple sclerosis from other white matter lesions.•The…”
Get full text

Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis by Shinohara, R T, Oh, J, Nair, G, Calabresi, P A, Davatzikos, C, Doshi, J, Henry, R G, Kim, G, Linn, K A, Papinutto, N, Pelletier, D, Pham, D L, Reich, D S, Rooney, W, Roy, S, Stern, W, Tummala, S, Yousuf, F, Zhu, A, Sicotte, N L, Bakshi, R

“…MR imaging can be used to measure structural changes in the brains of individuals with multiple sclerosis and is essential for diagnosis, longitudinal…”
Get full text

An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions by Dworkin, J D, Linn, K A, Oguz, I, Fleishman, G M, Bakshi, R, Nair, G, Calabresi, P A, Henry, R G, Oh, J, Papinutto, N, Pelletier, D, Rooney, W, Stern, W, Sicotte, N L, Reich, D S, Shinohara, R T

“…Lesion load is a common biomarker in multiple sclerosis, yet it has historically shown modest association with clinical outcome. Lesion count, which…”
Get full text